Ophthalmology in China

Previous Articles     Next Articles

70 years development of ophthalmic imaging technology in China

ZHOU Nan, WEI Wen-bin.   

  1. Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
     
  • Received:2019-07-04 Online:2019-07-25 Published:2019-07-30
  • Contact: WEI Wen-bin, Email: weiwenbintr@163.com

Abstract:

Since the founding of the People's Republic of China, ophthalmic imaging technology has undergone 70 years of development, and has changed rapidly. From fluorescein fundus angiography and indocyanine green fundus angiography, ocular ultrasound examination, optic coherence tomography(OCT) and OCT angiography(OCTA), fundus camera, fundus autofluoresence examination, to computed tomography (CT) and magnetic resonance imaging (MRI), they have greatly deepened the understanding of ophthalmic diseases for us. Many diseases that could not be seen intuitively in the past have been further recognized by means of imaging examination, which has greatly promoted the improvement of the overall level of ophthalmic diagnosis and treatment in China. Especially the appearance of OCT and OCTA is a landmark progress in ophthalmic imaging. Summarizing the progress of ophthalmic imaging technology in China in the past 70 years is not only the review of the development of ophthalmic imaging, but also the guiding significance for the overall development of ophthalmology. (Ophthalmol CHN, 2019, 28: 241-244)

Key words: ophthalmic imaging technology, China, development